Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Mahonia repens
Low-growing North American mahonia with berberine; used for skin conditions and digestion.
Mahonia repens is a low-growing North American barberry species rich in berberine and other isoquinoline alkaloids. It is traditionally used for skin conditions such as psoriasis and eczema, as well as digestive disorders and infections. Modern research supports its antimicrobial, anti-psoriatic, and digestive tonic properties, though clinical evidence remains limited (Level C).
Berberine, the primary alkaloid, exerts antimicrobial effects by inhibiting bacterial DNA gyrase and topoisomerase IV, and disrupts fungal cell membranes. In psoriasis, berberine suppresses keratinocyte proliferation via inhibition of the MAPK/ERK pathway and reduces inflammatory cytokines such as IL-17 and TNF-α. The digestive tonic action may involve stimulation of bile secretion and modulation of gut microbiota. Berbamine and oxyacanthine contribute additional anti-inflammatory and immunomodulatory effects through NF-κB inhibition.
Low-growing North American mahonia with berberine; used for skin conditions and digestion.
Mahonia repens is a low-growing North American barberry species rich in berberine and other isoquinoline alkaloids. It is traditionally used for skin conditions such as psoriasis and eczema, as well as digestive disorders and infections. Modern research supports its antimicrobial, anti-psoriatic, and digestive tonic properties, though clinical evidence remains limited (Level C).
Berberine, the primary alkaloid, exerts antimicrobial effects by inhibiting bacterial DNA gyrase and topoisomerase IV, and disrupts fungal cell membranes. In psoriasis, berberine suppresses keratinocyte proliferation via inhibition of the MAPK/ERK pathway and reduces inflammatory cytokines such as IL-17 and TNF-α. The digestive tonic action may involve stimulation of bile secretion and modulation of gut microbiota. Berbamine and oxyacanthine contribute additional anti-inflammatory and immunomodulatory effects through NF-κB inhibition.